Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications

Around 80–90% of prostate cancer (PCa) cases are dependent on androgens at initial diagnosis; hence, androgen ablation therapy directed toward a reduction in serum androgens and the inhibition of androgen receptor (AR) is generally the first therapy adopted. However, the patient’s response to androg...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cells
Main Authors: Aurilio, Gaetano, Cimadamore, Alessia, Mazzucchelli, Roberta, Lopez-Beltran, Antonio, Verri, Elena, Scarpelli, Marina, Massari, Francesco, Cheng, Liang, Santoni, Matteo, Montironi, Rodolfo
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7763510/
https://ncbi.nlm.nih.gov/pubmed/33321757
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9122653
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados